JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
Clinical trial NCT03538301 · COMPLETED
Trial details
- NCT number
- NCT03538301
- Sponsor
- Nitto Denko Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2022-08-24
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.